These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 17337137)

  • 1. Nasal administration of an angiotensin antagonist in the rat model: effect of bioadhesive formulations on the distribution of drugs to the systemic and central nervous systems.
    Charlton ST; Davis SS; Illum L
    Int J Pharm; 2007 Jun; 338(1-2):94-103. PubMed ID: 17337137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of bioadhesive polymers as delivery systems for nose to brain delivery: in vitro characterisation studies.
    Charlton ST; Davis SS; Illum L
    J Control Release; 2007 Apr; 118(2):225-34. PubMed ID: 17261340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution and clearance of bioadhesive formulations from the olfactory region in man: effect of polymer type and nasal delivery device.
    Charlton S; Jones NS; Davis SS; Illum L
    Eur J Pharm Sci; 2007 Mar; 30(3-4):295-302. PubMed ID: 17223022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain targeting studies on buspirone hydrochloride after intranasal administration of mucoadhesive formulation in rats.
    Khan S; Patil K; Yeole P; Gaikwad R
    J Pharm Pharmacol; 2009 May; 61(5):669-75. PubMed ID: 19406007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of effect of ephedrine on the transport of drugs from the nasal cavity to the systemic circulation and the central nervous system.
    Charlton ST; Davis SS; Illum L
    J Drug Target; 2007 Jun; 15(5):370-7. PubMed ID: 17541846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation of intranasal mucoadhesive temperature-mediated in situ gel containing ropinirole and evaluation of brain targeting efficiency in rats.
    Khan S; Patil K; Bobade N; Yeole P; Gaikwad R
    J Drug Target; 2010 Apr; 18(3):223-34. PubMed ID: 20030503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting.
    Wang X; Chi N; Tang X
    Eur J Pharm Biopharm; 2008 Nov; 70(3):735-40. PubMed ID: 18684400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Permeation-enhancing effects of chitosan formulations on recombinant hirudin-2 by nasal delivery in vitro and in vivo.
    Zhang YJ; Ma CH; Lu WL; Zhang X; Wang XL; Sun JN; Zhang Q
    Acta Pharmacol Sin; 2005 Nov; 26(11):1402-8. PubMed ID: 16225765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary investigation of the nasal delivery of liposomal leuprorelin acetate for contraception in rats.
    Shahiwala A; Misra A
    J Pharm Pharmacol; 2006 Jan; 58(1):19-26. PubMed ID: 16393460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid-onset intranasal delivery of metoclopramide hydrochloride. Part I. Influence of formulation variables on drug absorption in anesthetized rats.
    Zaki NM; Awad GA; Mortada ND; Abd ElHady SS
    Int J Pharm; 2006 Dec; 327(1-2):89-96. PubMed ID: 16942844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbamazepine uptake into rat brain following intra-olfactory transport.
    Barakat NS; Omar SA; Ahmed AA
    J Pharm Pharmacol; 2006 Jan; 58(1):63-72. PubMed ID: 16393465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of brain delivery and copulation by intranasal apomorphine hydrochloride.
    Lu W; Jiang W; Chen J; Yin M; Wang Z; Jiang X
    Int J Pharm; 2008 Feb; 349(1-2):196-205. PubMed ID: 17904315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties.
    Zaki NM; Awad GA; Mortada ND; Abd Elhady SS
    Eur J Pharm Sci; 2007 Dec; 32(4-5):296-307. PubMed ID: 17920822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery.
    Alpar HO; Somavarapu S; Atuah KN; Bramwell VW
    Adv Drug Deliv Rev; 2005 Jan; 57(3):411-30. PubMed ID: 15560949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Site-specific drug delivery systems. III. Nasal drug delivery].
    Szente V; Zelkó R
    Acta Pharm Hung; 2008; 78(2):87-90. PubMed ID: 18807389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid-onset intranasal delivery of metoclopramide hydrochloride Part II: Safety of various absorption enhancers and pharmacokinetic evaluation.
    Zaki NM; Mortada ND; Awad GA; Abd ElHady SS
    Int J Pharm; 2006 Dec; 327(1-2):97-103. PubMed ID: 16959453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and evaluation of bioadhesive in-situ nasal gel of ketorolac tromethamine.
    Chelladurai S; Mishra M; Mishra B
    Chem Pharm Bull (Tokyo); 2008 Nov; 56(11):1596-9. PubMed ID: 18981612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of physicochemical properties on intranasal nanoparticle transit into murine olfactory epithelium.
    Mistry A; Glud SZ; Kjems J; Randel J; Howard KA; Stolnik S; Illum L
    J Drug Target; 2009 Aug; 17(7):543-52. PubMed ID: 19530905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chitosan and cyclodextrin in intranasal microemulsion for improved brain buspirone hydrochloride pharmacokinetics in rats.
    Bshara H; Osman R; Mansour S; El-Shamy Ael-H
    Carbohydr Polym; 2014 Jan; 99():297-305. PubMed ID: 24274510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The application of mucoadhesive polymers in nasal drug delivery.
    Jiang L; Gao L; Wang X; Tang L; Ma J
    Drug Dev Ind Pharm; 2010 Mar; 36(3):323-36. PubMed ID: 19735210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.